| Primary |
| Rheumatoid Arthritis |
63.9% |
| Systemic Lupus Erythematosus |
10.9% |
| Crohn's Disease |
3.1% |
| Prophylaxis |
3.0% |
| Hypertension |
3.0% |
| Colitis Ulcerative |
2.2% |
| Osteoporosis |
2.0% |
| Gastritis |
1.6% |
| Gastritis Prophylaxis |
1.6% |
| Polyarthritis |
1.0% |
| Convulsion |
0.9% |
| Depression |
0.9% |
| Constipation |
0.8% |
| Juvenile Arthritis |
0.8% |
| Neuropathy Peripheral |
0.8% |
| Asthenopia |
0.7% |
| Asthma |
0.7% |
| Pain |
0.7% |
| Urticaria Chronic |
0.7% |
| Ankylosing Spondylitis |
0.7% |
|
| Pyrexia |
9.3% |
| Pneumonia |
8.2% |
| Sepsis |
8.2% |
| Vomiting |
7.5% |
| Urinary Tract Infection |
6.7% |
| Septic Shock |
6.3% |
| Crohn's Disease |
6.0% |
| Gastroenteritis |
5.6% |
| Anaemia |
5.2% |
| Osteonecrosis |
4.9% |
| Colitis Ulcerative |
4.5% |
| Subcutaneous Abscess |
4.1% |
| Renal Failure |
3.4% |
| Appendicitis |
3.0% |
| Convulsion |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Psoriasis |
3.0% |
| Renal Failure Acute |
3.0% |
| Cholecystitis |
2.6% |
| Dyspnoea |
2.6% |
|
| Secondary |
| Rheumatoid Arthritis |
61.8% |
| Product Used For Unknown Indication |
12.5% |
| Drug Use For Unknown Indication |
6.2% |
| Hypertension |
3.4% |
| Systemic Lupus Erythematosus |
3.0% |
| Polyarthritis |
2.8% |
| Diabetes Mellitus |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Gastritis Prophylaxis |
1.0% |
| Juvenile Arthritis |
1.0% |
| Prophylaxis |
0.8% |
| Hyperlipidaemia |
0.7% |
| Inflammation |
0.7% |
| Osteoporosis |
0.7% |
| Psoriatic Arthropathy |
0.6% |
| Seronegative Rheumatoid Arthritis |
0.6% |
| Blood Cholesterol |
0.5% |
| Cardiovascular Event Prophylaxis |
0.5% |
| Hypothyroidism |
0.5% |
| Mineral Supplementation |
0.5% |
|
| Breast Cancer |
8.1% |
| Cellulitis |
8.1% |
| Gastric Cancer |
8.1% |
| Lung Adenocarcinoma Metastatic |
8.1% |
| Breast Cancer In Situ |
7.0% |
| Sepsis |
7.0% |
| Appendicitis |
5.8% |
| Basal Cell Carcinoma |
5.8% |
| Colon Cancer Metastatic |
4.7% |
| Lung Adenocarcinoma |
4.7% |
| Pulmonary Embolism |
4.7% |
| Cholecystitis |
3.5% |
| Nasopharyngitis |
3.5% |
| Pneumonia |
3.5% |
| Prostate Cancer |
3.5% |
| Urticaria |
3.5% |
| Ventricular Extrasystoles |
3.5% |
| Abscess Oral |
2.3% |
| Autoimmune Hepatitis |
2.3% |
| Bladder Transitional Cell Carcinoma |
2.3% |
|
| Concomitant |
| Rheumatoid Arthritis |
43.0% |
| Product Used For Unknown Indication |
27.3% |
| Drug Use For Unknown Indication |
7.9% |
| Polyarthritis |
3.7% |
| Hyperlipidaemia |
2.4% |
| Prophylaxis Against Graft Versus Host Disease |
2.4% |
| Hypertension |
1.8% |
| Arthralgia |
1.6% |
| Medical Diet |
1.6% |
| Hyperuricaemia |
1.0% |
| Infection Prophylaxis |
1.0% |
| Blood Cholesterol Abnormal |
0.8% |
| Cardiovascular Event Prophylaxis |
0.8% |
| Glaucoma |
0.8% |
| Pain |
0.8% |
| Rhinitis Seasonal |
0.8% |
| Vitamin Supplementation |
0.8% |
| Diabetes Mellitus |
0.5% |
| Insomnia |
0.5% |
| Musculoskeletal Pain |
0.5% |
|
| Graft Versus Host Disease |
8.8% |
| Thrombocytopenia |
8.8% |
| Weight Decreased |
8.8% |
| Articular Calcification |
5.9% |
| Chronic Obstructive Pulmonary Disease |
5.9% |
| Cytolytic Hepatitis |
5.9% |
| Diarrhoea |
5.9% |
| Herpes Zoster |
5.9% |
| Meningitis Meningococcal |
5.9% |
| Pneumocystis Jiroveci Pneumonia |
5.9% |
| Pulmonary Mass |
5.9% |
| Agranulocytosis |
2.9% |
| Angina Pectoris |
2.9% |
| Arthralgia |
2.9% |
| Autoimmune Hepatitis |
2.9% |
| Bladder Transitional Cell Carcinoma |
2.9% |
| Blindness Unilateral |
2.9% |
| C-reactive Protein Increased |
2.9% |
| Cholelithiasis |
2.9% |
| Conjunctival Haemorrhage |
2.9% |
|
